Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

31 results about "Glycomics" patented technology

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the omics naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Methods for making microarrays and their uses

The present invention provides microarrays that can be analysed by more than one technique using a non-covalent ligand attachment strategy to solid supports such as indium tin oxide (ITO) covered transparent glass slides. This provides, inter alia, glycan arrays on a micrometer scale which allow multimodal readout by MALDI-Tof-MS, fluorescence and optical microscopy. Glycans functionalized with a C5-aminolinker were attached in situ on a picomolar scale to a hydrophobic tag bound to this surface, thus avoiding the wasteful off-chip ligand tagging of other approaches. Glycan arrays prepared using this methodology were analysed both with a fluorescence scanner and by on-chip MALDI-mass spectrometry in a series of glycomics experiments specifically requiring a multimodal readout.
Owner:ASOCIACION CENT DE INVESTIGACION COOP & BIOMATERIALES - CIC BIOMAGUNE

Vivo isotopic labeling method for quantitative glycomics

The present invention relates to a method of isotopically labeling glycans and in facilitating high throughput quantitative / comparative analysis of glycomic compositions of biological cells. The method is applicable inter alia for identifying differentiated cells and their glycomic characteristics, differentiation conditions, disease and / or therapeutic progression, diagnosing disease states, determining drug activity, establishing manufacturing efficiencies and for determining the half-life of glycans in cells.
Owner:UNIV OF GEORGIA RES FOUND INC

Cysteine hydrazide nicotinamide for glycomics and glycoproteomics uses

A cysteine hydrazide nicotinamide (Cyhn) reagent designed for the enrichment of bacterial glycoproteins is provided. Methods for purification of free oligosaccharides and their analysis are also provided.
Owner:CALIFORNIA INST OF TECH

In vivo isotopic labeling method for quantitative glycomics

The present invention relates to a method of isotopically labeling glycans and in facilitating high throughput quantitative / comparative analysis of glycomic compositions of biological cells. The method is applicable inter alia for identifying differentiated cells and their glycomic characteristics, differentiation conditions, disease and / or therapeutic progression, diagnosing disease states, determining drug activity, establishing manufacturing efficiencies and for determining the half-life of glycans in cells.
Owner:UNIV OF GEORGIA RES FOUND INC

Application of a method for obtaining and detecting monosaccharides by blood degradation in cancer detection

The invention belongs to the field of medicines, and relates to an application of a method for degrading all carbohydrate chains in the blood to be monosaccharide and detecting the monosaccharide in cancer detection. A sample in the method for degrading the blood to obtain the monosaccharide and detecting the monosaccharide is the blood, and the cancer includes lung cancer, gastric cancer, ovarian cancer, penis cancer, esophagus cancer, oral cancer, biliary duct cancer, breast cancer, adenocarcinoma perampullaire, rectal cancer and bladder cancer. The method has the characteristics of simplicity and easiness in operation steps, easiness in popularization, short detection time, low requirement on the instrument, low detection cost, less consumption of blood and the like. The result displays that based on the content of eight monosaccharides in the blood, not only can a normal person and a cancer patient be distinguished, but also different cancers can be distinguished. The method for simplifying glycomics knowledge and applying in the detection of the biomarker of blood is first created in the world.
Owner:OCEAN UNIV OF CHINA

Method for multiply detecting carbohydrate chain structure of glycoprotein through antibody-assisted lectin liquid-phase suspension chip

The invention belongs to the technical field of biology and relates to a method for multiply detecting a carbohydrate chain structure of glycoprotein through an antibody-assisted lectin liquid-phase suspension chip. According to the method, lectins are coupled to magnetic beads marked with different dyes, the magnetic beads which are coupled with different lectins are identified through a Bioplex detection system, and different glycoforms on the same protein can be simultaneously detected by adding the magnetic beads which are coupled with different lectins and have different serial numbers into a reaction, so that the detection flux of the carbohydrate chain structure is remarkably improved. According to the method, the carbohydrate chain structure on the glycoprotein can be quickly and specifically detected with high flux. The method can be further applied to detection of a clinical biological marker and provides an efficient way for research on disease glycomics.
Owner:FUDAN UNIV

Bioanalytic System Business Methods

Business methods useful for identifying, and marketing or commercializing glycomics-related diagnostic, therapeutic and / or imaging probe products are disclosed. Patient test samples are screened for the presence of glycan-binding moieties to produce binding data. Binding data is collected into a database. One or more bioinformatic algorithms are used to process the collected binding data to identify one or more diagnostic, therapeutic or imaging probe products. Identified products are collaboratively or independently, marketed or commercialized. Business methods are also provided for marketing or commercializing products for producing oligosaccharides, reactive antibody products, and monoclonal antibody cocktail products. Business methods of conducting glycomics-related cancer trials are also disclosed.
Owner:CELLEXICON

Method for rapid enzymolysis release, solid phase concentration and mass spectrometry of N-glycan

The invention belongs to the field of the glycoproteomics and glycomics, and relates to a method for rapid enzymolysis release, solid phase concentration and mass spectrometry of N-glycan. The methodcomprises the following steps of absorbing a solution containing a glycoprotein sample by using a degreasing cotton material, and performing high-temperature rapid PNGase F enzymolysis on the cotton to release N-glycan; adjusting solution environment after the enzymolysis is finished, and adsorbing free glycan on the degreasing cotton material by utilizing the high-density hydroxy and hydrogen bond of the glycan and like effects on the surface of the degreasing cotton material, and then cleaning and removing non-glycan molecules such as protein, polypeptide and like which are not bonded with the degreasing cotton material, and finally eluting the adsorbed glycan with the aqueous solution, and feeding into mass spectrometry. Through the method disclosed by the invention, the used material is cheap and easy to obtain, the preparation is easy, the operation is simple and convenient, the high-speed enzymolysis of the N-glycoprotein and the high-selective concentration and high-sensitive mass spectrometry of the N-glycan can be realized.
Owner:FUDAN UNIV

Application of method for degrading blood to obtain monosaccharide and detecting monosaccharide in cancer detection

The invention belongs to the field of medicines, and relates to an application of a method for degrading all carbohydrate chains in the blood to be monosaccharide and detecting the monosaccharide in cancer detection. A sample in the method for degrading the blood to obtain the monosaccharide and detecting the monosaccharide is the blood, and the cancer includes lung cancer, gastric cancer, ovarian cancer, penis cancer, esophagus cancer, oral cancer, biliary duct cancer, breast cancer, adenocarcinoma perampullaire, rectal cancer and bladder cancer. The method has the characteristics of simplicity and easiness in operation steps, easiness in popularization, short detection time, low requirement on the instrument, low detection cost, less consumption of blood and the like. The result displays that based on the content of eight monosaccharides in the blood, not only can a normal person and a cancer patient be distinguished, but also different cancers can be distinguished. The method for simplifying glycomics knowledge and applying in the detection of the biomarker of blood is first created in the world.
Owner:OCEAN UNIV OF CHINA

Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring

Provided herein are methods for identifying new biomarkers for various diseases using proteomics, peptidomics, metabolics, proteoglycomics, glvcomics, mass spectrometry and machine learning. The present disclosure also provides glycopeptides as biomarkers for various diseases such as cancer and autoimmune diseases.
Owner:VENN BIOSCIENCES CORP

Method for rapid high-efficiency qualitative and quantitative analysis of N-sugar in virtue of high-performance liquid chromatography

The invention provides a method for rapid high-efficiency qualitative and quantitative analysis of N-sugar in virtue of high-performance liquid chromatography, belonging to the field of glycomic analysis. According to the method for rapid high-efficiency qualitative and quantitative analysis of N-sugar in virtue of high-performance liquid chromatography, a microwave-aided means is employed for accelerating the deglycosylation reaction of N-sugar, and a derivative reagent AQC is cooperatively used for marking glucosamine directly obtained through enzyme digestion, so high-efficiency high-sensitivity qualitative and quantitative analysis of N-sugar is realized.
Owner:EZHOU INST OF IND TECH HUAZHONG UNIV OF SCI & TECH +1

Isotope-labeled bionic sugar or sugar group and preparation method and applications thereof

The invention discloses isotope-labeled bionic sugar or sugar group and a preparation method and applications thereof. Specifically, the isotope-labeled bionic sugar or sugar group disclosed by the invention include a reducing alcohol hydroxyl located at the reducing end of the sugar chain and an isotope label, wherein the molecular weight of each bionic sugar chain is increased by 3 Daltons compared with that of corresponding unmodified sugar chain, and the bionic sugar (group) has the same sugar chain composition and similar sugar chain abundance as the unmodified sugar (group). The invention also provides a method for analyzing the sugar group in a sample by using the isotope-labeled bionic sugar or the sugar group, and the method comprises the step: carrying out mass analysis on the mixture of the isotope-labeled internal standard bionic sugar chain and the sample sugar chain which is not labeled by the isotope so as to carry out qualitative and / or quantitative analysis on the sugar group in the sample. The method has the advantages of both the simple operation of a non-isotope-labeled glycomics method and the accuracy of an isotope-labeled glycomics method, can be used for high-throughput detection, and has wide application prospect.
Owner:FUDAN UNIV

Preparation method for monoclonal antibody library of tumor mucoprotein glycopeptide epitope

The invention relates to a preparation method for a monoclonal antibody library of tumor mucoprotein glycopeptide epitope. The method comprises the following steps of: extrapolating all possibly occurring tumor glycopeptide sequences according to an amino acid sequence of mucoprotein; then transfecting tumor cells by using mucoprotein genes to obtain immunogens for immuning a mice to prepare monoclonal antibodies; synthesizing all extrapolated glycopeptides by using a chemical synthesis method and labeling with biotins respectively to obtain the biotin-labeled glycopeptides for screening the monoclonal antibodies; and finally, immuning the mice by using the immunogens to prepare hybridoma, screening the hybridoma by using the biotin-labeled glycopeptides, and sorting out the monoclonal antibody aiming at each specific glycopeptide structure. In the invention, an immune glycomic method is used for the first time to extrapolate all possibly occurring epitopes of highly glycosylated tandem repeat polypeptide segments during cancerization. The glycopeptide antigens are obtained by using the chemical synthesis method; and then the synthesized glycopeptides are used for tagging the monoclonal antibodies.
Owner:JIANGSU UNIV +1

Radioactive multiplexing analytical methods for biomarkers discovery

A novel analytical method involves labeling samples with different radioactive labeling agents, mixing and subjecting the mixture to any separation technique, and then differentially detecting and quantifying subcomponents from each sample for comparison. The novel technique exploits the differences in radiation energy or half-life between isotopes to make differential detection and quantification of labels possible. Detailed methods for differential detection and quantification are also described as well as the construction and application of hardware and software to enable and enhance such a process. This method is useful in finding molecular differences between two samples in differential proteomics, phosphor-proteomics, glycomics, metabolomics, transcriptomics, genomics and diagnostic applications.
Owner:PROTEOMYX

Method for N-carbohydrate chain solid phase enrichment and mass spectrometry

InactiveCN105372356AIncreased Selectivity in Mass SpectrometryStrong chelating abilityComponent separationMagnetite NanoparticlesChelation
The invention belongs to the field of sugar proteomics and glycomics analysis, and relates to a method for using phosphoro-amidate for deriving an N-carbohydrate chain and using Ti4+modifiaiton magnetic nanoparticles for enriching the derived N-carbohydrate chain. The method comprises the steps that firstly, phosphate radicals are introduced to the N-carbohydrate chain derived from the phosphoro-amidate at the reducing end of the N-carbohydrate chain, then the Ti4+modifiaiton magnetic nanoparticles Fe3O4@Ti4+ are placed into a derived carbohydrate chain solution, the carbohydrate chain is fixed to the magnetic nanoparticles through a chelation reaction between the phosphate radicals in the Ti4+ and the carbohydrate chain, non-carbohydrate chain molecules (such as protein, polypeptide, inorganic salt and the like) not combined with the nanoparticles are cleaned away and removed, and finally the captured carbohydrate chain is disengaged from the materials on the alkaline condition and fed into a mass spectrometry carbohydrate chain. The method is simple in steps, convenient to implement, rapid, efficient and capable of achieving high-sensitive and high-selective mass spectrometry of the N-carbohydrate chain.
Owner:FUDAN UNIV

Cysteine hydrazide nicotinamide for glycomics and glycoproteomics uses

A cysteine hydrazide nicotinamide (Cyhn) reagent designed for the enrichment of bacterial glycoproteins is provided. Methods for purification of free oligosaccharides and their analysis are also provided.
Owner:CALIFORNIA INST OF TECH

Methods for making microarrays and their uses

The present invention provides microarrays that can be analysed by more than one technique using a non-covalent ligand attachment strategy to solid supports such as indium tin oxide (ITO) covered transparent glass slides. This provides, inter alia, glycan arrays on a micrometer scale which allow multimodal readout by MALDI-Tof-MS, fluorescence and optical microscopy. Glycans functionalized with a C5-aminolinker were attached in situ on a picomolar scale to a hydrophobic tag bound to this surface, thus avoiding the wasteful off-chip ligand tagging of other approaches. Glycan arrays prepared using this methodology were analysed both with a fluorescence scanner and by on-chip MALDI-mass spectrometry in a series of glycomics experiments specifically requiring a multimodal readout.
Owner:ASOCIACION CENT DE INVESTIGACION COOP & BIOMATERIALES - CIC BIOMAGUNE

General low-cost quaternary ammonium salt sugar chain isotope labeling reagent and synthesis method

ActiveCN112778194ASimplified peak formImproving MS Detection SensitivityOrganic chemistry methodsMaterial analysis by electric/magnetic meansStable Isotope LabelingQuinoline
The invention relates to the technical field of bioglycomics analysis, and discloses a general low-cost quaternary ammonium salt sugar chain isotope labeling reagent and a synthesis method thereof. The reagent comprises a labeling reagent deuterated 7-4-methyl-1-(2-hydrazino-2-oxoethyl)-pyridinium bromide in a heavy isotope form and a labeling reagent 4-methyl-1-(2-hydrazino-2-oxoethyl)-pyridinium bromide corresponding to the labeling reagent deuterated 7-4-methyl-1-(2-hydrazino-2-oxoethyl)-pyridinium bromide in a light isotope form. The reagent can be used for mass spectrum high-sensitivity and high-accuracy relative quantitative analysis of biological reducing sugar chains of different molecular weight segments; according to the reagent provided by the invention, the mass spectrometric detection sensitivity of the sugar chain can be greatly improved; meanwhile, the method is suitable for mass spectrum relative quantitative analysis of reducing sugar chains with relatively small and large molecular weights; the synthesis raw materials are low in cost, and the defect that hydrazide quaternary ammonium salt stable isotope labeling reagents synthesized based on deuterated isoquinoline are high in cost is overcome.
Owner:NORTHWEST UNIV

Human lectin/human lectin-like chip for glycosylation detection and preparation method thereof

The invention discloses a human lectin / human lectin-like chip for glycosylation detection in the field of biological sciences and a preparation method, which is constructed based on recombinant human lectin / human lectin-like protein. The recombinant proteins are 60 kinds of human lectin / human lectin-like proteins capable of recognizing and binding different sugar groups. Compared with the traditional plant lectin chip, the human lectin / human lectin chip has more specific recognition ability and stronger binding ability to complex glycoforms of higher vertebrate samples. Human lectin / human lectin-like chips provide a new technology platform for glycomics research and can be widely used in glycosylation research of humans or other mammals.
Owner:SHANGHAI JIAOTONG UNIV

Method and system for identifying Denovo by N-sugar chain structure based on mass spectrum data

The invention belongs to the technical field of glycomics, and discloses an N-sugar chain structure identification Denovo method and system based on mass spectrometric data, and the method comprises the following steps: extracting structure and composition information of sugar chain fragment ions in the mass spectrometric data, and carrying out N-sugar chain identification based on a basic peak, a cross peak and a generalized monosaccharide dictionary, and reducing the search space of the identification result candidate structure by using a pruning strategy to obtain an N-sugar chain structure corresponding to the mass spectrum. On the basis of mass spectrum data of the N-sugar chain and the idea of Denovo, the structure and composition information of sugar chain fragment ions in the mass spectrum data is extracted, and the N-sugar chain structure corresponding to the mass spectrum is identified. In the identification process, basic peaks and cross peaks are introduced, and N-carbohydrate chain identification is carried out based on the basic peaks and the cross peaks; a generalized monosaccharide dictionary is introduced, the spectrogram quality is improved, and the robustness of the identification method to noise in mass spectrum data is improved; and reducing the search space of the identification result candidate structure by using a pruning strategy. According to the invention, the mass spectrum identification quality is improved.
Owner:XIDIAN UNIV

A kind of universal low-cost quaternary ammonium salt sugar chain isotope labeling reagent and synthesis method

ActiveCN112778194BSimplified peak formImproving MS Detection SensitivityOrganic chemistry methodsMaterial analysis by electric/magnetic meansStable Isotope LabelingQuinoline
The invention relates to the technical field of biological glycomic analysis, and discloses a general low-cost quaternary ammonium salt sugar chain isotope labeling reagent and a synthesis method, including a labeling reagent in the form of heavy isotope deuterated 7-4-methyl-1-( 2-hydrazino-2-oxoethyl)-pyridinium bromide and its corresponding labeling reagent in light isotopic form 4-methyl-1-(2-hydrazino-2-oxoethyl)-pyridinium bromide Onium; can be used for mass spectrometry high-sensitivity and high-accuracy relative quantitative analysis of bioreducing sugar chains of different molecular weight segments; the reagent provided by the invention can greatly improve the mass spectrometry detection sensitivity of sugar chains; it is suitable for small and large molecular weight reducing sugar chains at the same time Relative quantitative analysis of sugar chains by mass spectrometry; low cost of synthetic raw materials, overcoming the disadvantage of high cost of hydrazide-based quaternary ammonium salt stable isotope labeling reagents synthesized based on deuterated isoquinoline.
Owner:NORTHWEST UNIV

Synthetic biometric generator based on real biometric data tags

Creating synthetic biological data for a subject may include: (a) receiving a real biological data tag derived from a biological sample of the subject; (b) creating an input vector based on the real biological data tag; (c) inputting the input vector into a machine learning platform; (d) generating a predicted biodata tag for the subject based on the input vector, wherein the predicted biodata tag comprises synthetic biodata specific to the subject; and (e) preparing a report comprising the synthetic biological data of the subject. The biological pathway activation tag may be genomic, transcriptomic, proteomic, metabonomic, lipidomic, glycomic, methylomic, or secretomic. A potential code of the input vector in a potential space of the machine learning platform is adjusted with at least one constraint of an attribute of the subject such that the predicted biodata tag is based on the at least one constraint.
Owner:INSILICO MEDICINE IP LTD

Sugar chain relative quantitative isotope labeling mass spectrum derivatization reagent

The invention discloses a sugar chain relative quantitative isotope labeling mass spectrum derivatization reagent, and particularly relates to a d0-DPBOC reagent and a d5-DPBOC reagent. The structureof the reagent contains an N-hydroxysuccinimide activated carboxyl structure so that a sugar chain of glycoprotein digested by streptavidin E can be labeled under an alkaline condition, and the retention of the labeled sugar chain in a reversed-phase chromatographic column is enhanced. Besides, the reagent contains a d0 / d5 stable light and heavy isotope benzoyl (d0 / d5-Benzoyl acyl) structure, relative quantitative analysis of the sugar chain can be carried out based on an isotope ratio (d0 / d5) by utilizing a liquid chromatography-mass spectrometry technology, and a sugar chain standard substance is not needed. A novel high-sensitivity isotope mass spectrum derivatization reagent is provided for research of differential glycomics and screening of new biomarkers of disease carbohydrate chains.
Owner:YANBIAN UNIV

Preparation of samples for deep N-glycomic analysis of serum for capillary electrophoresis and CE-ESI-MS by temperature gradient denaturation and scaling

A sample preparation workflow for promoting deep N-glycomics analysis of human serum by capillary electrophoresis (CE-LIF) with laser-induced fluorescence detection adapts to higher sample concentration requirements of electrospray ionization mass spectrometry (CE-ESI-MS) linked to capillary electrophoresis. A temperature gradient denaturation scheme is applied to amine functionalized magnetic bead dispensed glycoproteins to avoid precipitation. This also results in a significant reduction in free sugar content in serum, which results in the release of PNGase F mediated N-linked carbohydrates. The released oligosaccharide is labeled with aminopyrene-trisulfonate using an improved evaporation labeling scheme. The workflow provides an appropriate amount of material, for example, for CE-ESI-MS analysis performed in an anionizing mode.
Owner:DH TECH DEVMENT PTE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products